Teva, AbbVie may pay billions to settle opioid lawsuits
Teva Earnings: Scale Needs To Pay Off Soon - Bloomberg
Teva's Trouble Was Predicted. Path to Recovery Not as Clear - Bloomberg
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
Teva Considers 10,000 Job Cuts - Bloomberg
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - Bloomberg
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
Teva's CEO Was $2.8 Billion Down on His Second Day on the Job - Bloomberg
Teva Pharmaceuticals - Wikipedia
HSBC downgrades Teva on uncertainty surrounding DOJ's reported generic drug investigation
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva Pays $420 Million to End Generic-Drug Securities Suit (1)
Teva's Budding Blockbuster Drugs Lend Respite From Legal Concerns - Bloomberg
Teva Says 2018 Profit Will Keep Falling as Generic Drug Slump Persists - Bloomberg
Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech
Pharma Industry Champion Bloomberg: Generic Drugs Could Be Harmful - The Official Myti-Herbs Online Store
Teva Faces Rocky Path to Recovery After Debt | Fortune
Teva's Adderall Shortage Expected to Continue Into March, FDA Says - BNN Bloomberg
Teva stock drops after conspiracy allegations on hiking drug prices
Teva's Working With Evercore to Review Debt Options - Bloomberg
Building on Strong First Quarter, Teva Raises 2018 Outlook | Ctech
Teva Ramps Up Sales With Medis, Respiratory Units - Bloomberg
Teva trades lower after Jefferies cuts rating to Hold | Seeking Alpha
